Cargando…

Oral cyclosporine therapy for refractory severe vernal keratoconjunctivitis

We report the success of oral cyclosporine therapy in a patient with severe vision-threatening vernal keratoconjunctivitis. A child presented with severe allergy which was not controlled with topical steroids, cyclosporine and mast cell stabilizers. Oral steroids were required repeatedly to suppress...

Descripción completa

Detalles Bibliográficos
Autores principales: Gokhale, Nikhil S, Samant, Rohini, Sharma, Vishnu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3361821/
https://www.ncbi.nlm.nih.gov/pubmed/22569387
http://dx.doi.org/10.4103/0301-4738.95878
_version_ 1782234156929908736
author Gokhale, Nikhil S
Samant, Rohini
Sharma, Vishnu
author_facet Gokhale, Nikhil S
Samant, Rohini
Sharma, Vishnu
author_sort Gokhale, Nikhil S
collection PubMed
description We report the success of oral cyclosporine therapy in a patient with severe vision-threatening vernal keratoconjunctivitis. A child presented with severe allergy which was not controlled with topical steroids, cyclosporine and mast cell stabilizers. Oral steroids were required repeatedly to suppress inflammation. Child showed a dramatic improvement and stabilization with oral cyclosporine therapy. Oral cyclosporine therapy can be tried in severe vision-threatening allergy refractory to conventional therapy.
format Online
Article
Text
id pubmed-3361821
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-33618212012-06-01 Oral cyclosporine therapy for refractory severe vernal keratoconjunctivitis Gokhale, Nikhil S Samant, Rohini Sharma, Vishnu Indian J Ophthalmol Brief Communications We report the success of oral cyclosporine therapy in a patient with severe vision-threatening vernal keratoconjunctivitis. A child presented with severe allergy which was not controlled with topical steroids, cyclosporine and mast cell stabilizers. Oral steroids were required repeatedly to suppress inflammation. Child showed a dramatic improvement and stabilization with oral cyclosporine therapy. Oral cyclosporine therapy can be tried in severe vision-threatening allergy refractory to conventional therapy. Medknow Publications & Media Pvt Ltd 2012 /pmc/articles/PMC3361821/ /pubmed/22569387 http://dx.doi.org/10.4103/0301-4738.95878 Text en Copyright: © Indian Journal of Ophthalmology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Brief Communications
Gokhale, Nikhil S
Samant, Rohini
Sharma, Vishnu
Oral cyclosporine therapy for refractory severe vernal keratoconjunctivitis
title Oral cyclosporine therapy for refractory severe vernal keratoconjunctivitis
title_full Oral cyclosporine therapy for refractory severe vernal keratoconjunctivitis
title_fullStr Oral cyclosporine therapy for refractory severe vernal keratoconjunctivitis
title_full_unstemmed Oral cyclosporine therapy for refractory severe vernal keratoconjunctivitis
title_short Oral cyclosporine therapy for refractory severe vernal keratoconjunctivitis
title_sort oral cyclosporine therapy for refractory severe vernal keratoconjunctivitis
topic Brief Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3361821/
https://www.ncbi.nlm.nih.gov/pubmed/22569387
http://dx.doi.org/10.4103/0301-4738.95878
work_keys_str_mv AT gokhalenikhils oralcyclosporinetherapyforrefractoryseverevernalkeratoconjunctivitis
AT samantrohini oralcyclosporinetherapyforrefractoryseverevernalkeratoconjunctivitis
AT sharmavishnu oralcyclosporinetherapyforrefractoryseverevernalkeratoconjunctivitis